GAMMA Investing’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $284K | Buy |
1,872
+474
| +34% | +$71.9K | 0.02% | 696 |
|
|
2025
Q1 | $210K | Buy |
1,398
+533
| +62% | +$80.2K | 0.02% | 738 |
|
|
2024
Q4 | $160K | Sell |
865
-176
| -17% | -$32.5K | 0.01% | 805 |
|
|
2024
Q3 | $205K | Buy |
1,041
+192
| +23% | +$37.8K | 0.02% | 613 |
|
|
2024
Q2 | $175K | Buy |
849
+412
| +94% | +$85.1K | 0.02% | 542 |
|
|
2024
Q1 | $118K | Buy |
437
+151
| +53% | +$40.9K | 0.02% | 582 |
|
|
2023
Q4 | $61.9K | Buy |
+286
| New | +$61.9K | 0.02% | 777 |
|